SWITCHING TNF-BLOCKERS: WHAT IS THE EVIDENCE

被引：0
|
作者：
Lie, E. [1 ]
机构：
[1] Diakonhjemmet Hosp, Oslo, Norway
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
ANKYLOSING-SPONDYLITIS; ADALIMUMAB; SAFETY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [41] THE RESPONSE TO TNF-BLOCKERS TREATMENT OF SPA PATIENTS IS INFLUENCED BY THE INTERPLAY BETWEEN HLA-B27 AND GUT MICROBIOTA COMPOSITION AT BASELINE
    Vallier, M.
    Chamaillard, M.
    Ferreira, S.
    Menegatti, S.
    Bianchi, E.
    Rogge, L.
    Dougados, M.
    Miceli-Richard, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 996 - 996
  • [42] Retention Rate of TNF-blockers is Greater in Case of Advanced Spinal Ankylosis in Axial Spondyloarthritis: Data from the HUR-BIO Registry
    Kalyoncu, Umut
    Kilic, Levent
    Karadag, Omer
    Erden, Abdulsamet
    Bilgen, Sule Apras
    Akdogan, Ali
    Kiraz, Sedat
    Ertenli, Ihsan
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S66 - S66
  • [43] Cost per unit of radiographic outcome for TNF-blockers: Effect of disease duration, prior methotrexate failure, concomitant methotrexate use, and markers of inflammation
    Yocum, DE
    Bala, M
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 524 - 524
  • [44] TREATMENT OF ADULT JUVENILE IDIOPATHIC ARTHRITIS PATIENTS WITH TNF BLOCKERS AND EFFECT OF SWITCHING TO A SECOND ANTI-TNF AGENT
    Jarosova, K.
    Chroust, K.
    Buresova, L.
    Vencovsky, J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S14 - S14
  • [45] STEP-DOWN STRATEGY OF SPACING TNF-BLOCKERS INJECTIONS FOR ESTABLISHED RHEUMATOID ARTHRITIS IN REMISSION: A COST-UTILITY ANALYSIS BASED ON THE STRASS TRIAL
    Vanier, A.
    Tubach, F.
    Alfaiate, T.
    Mariette, X.
    Fautrel, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 178 - 178
  • [46] Autoantibodies and thrombophilia in RA:: TNFα and TNFα blockers
    Ferraccioli, GF
    Gremese, E
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (06) : 613 - 615
  • [47] The crossover approach to switching antipsychotics: What is the evidence?
    Remington, G
    Chue, P
    Stip, E
    Kopala, L
    Girard, T
    Christensen, B
    SCHIZOPHRENIA RESEARCH, 2005, 76 (2-3) : 267 - 272
  • [48] SWITCHING AMONG TUMOR NECROSIS FACTOR (TNF)-BLOCKERS IN US VETERANS WITH RHEUMATOID ARTHRITIS (RA)
    Cannon, G. W.
    DuVall, S. L.
    Hayden, C. L.
    Caplan, L.
    Curtis, J. R.
    Michaud, K.
    Mikuls, T. R.
    Reimold, A.
    Collier, D. H.
    Joseph, G. J.
    Harrison, D. J.
    Sauer, B. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1023 - 1024
  • [49] CHANGE OF ASDAS OVER 3 MONTHS IS A GOOD PREDICTIVE FACTOR FOR IMPROVEMENT OF METROLOGY INDEX AFTER LONG-TERM TREATMENT WITH TNF-BLOCKERS IN ANKYLOSING SPONDYLITIS
    Nam, E. J.
    Kwon, S. H.
    Eun, J. S.
    Kim, N. R.
    Kang, Y. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 758 - 758
  • [50] PROFILING OF SYSTEMIC IMMUNE RESPONSES IN AXIAL SPONDYLOARTHRITIS PATIENTS REVEALS STRIKINGLY DISTINCT CELLULAR AND MOLECULAR MECHANISMS OF ACTION OF IL-17A INHIBITORS AND TNF-BLOCKERS
    Rosine, N.
    Koturan, S.
    Guillemot, V.
    Leloup, C.
    Veress, F.
    Stephen, T.
    Yahia, H.
    Sellam, J.
    Berenbaum, F.
    Pietrosemoli, N.
    Bianchi, E.
    Richard, C. Miceli
    Rogge, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 881 - 881
12345